Tag: Ki-67

Come Challenge the Computer with Visiopharm at USCAP 2017

| March 3, 2017 | 0 Comments

Join Visiopharm at USCAP 2017 and learn about how we are transforming pathology! Come see demonstrations of Analysis of PD-L1 and CD Markers within the Tumor Micro-Environment Visualize and quantify biomarker expression with heatmaps and automated hot-spot detection The new, ultra-fast viewer which can be integrated into your digital pathology workflow Visit our booth to […]

Continue Reading

Proscia Introduces New Image Analysis Applications – Expands its Pathology Cloud Platform

| October 26, 2016 | 0 Comments

New applications on the platform enable acceleration of breakthroughs in the fight against cancer. Baltimore, MD; San Diego, CA (PRWEB) October 24, 2016 — Proscia Inc, the industry’s leading provider of cloud solutions for digital pathology, announced today the availability of powerful image analysis applications for cancer research on the company’s Proscia Pathology Cloud platform […]

Continue Reading

Three Events – One Product Family! Join ASI in March!

| March 17, 2015 | 0 Comments

Three Events – One Product Family! Join Applied Spectral Imaging at the following events in March to learn about ASI’s GenASIs Platform. Accurate. Standardized. Immediate USCAP 2015 – United States & Canadian Academy of Pathology Annual Meeting March 23-25 | Hynes Convention Center, Boston, MA, USA | Booth # 519 ACMG 2015 – Annual Clinical […]

Continue Reading

Join Applied Spectral Imaging at CAP’14 – THE Pathologists’ Meeting in Chicago, Il, USA September 7- 9, 2014

| September 2, 2014 | 0 Comments

Join ASI in booth # 223 at CAP’14 – THE Pathologists’ Meeting Come see ASI’s GenASIs HiPath, the latest Pathology Quantitative Diagnostic Aid, providing solutions for any sized lab! Ask questions from our experts, see a demo and get a comprehensive overview of our platform. GenASIs HiPath provides computer aided scoring and reporting for quantitative […]

Continue Reading

Visiopharm Fully Automated APP for Ki67 Assessment in Breast Cancer CE Marked for In-Vitro Diagnostic Use in Europe

| June 30, 2014 | 0 Comments

Exciting news from Visiopharm – their Ki67 diagnostic App has received the CE mark for in-vitro diagnostic use in Europe. The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended for automated tumor/stroma separation and computation of the Ki67 labelling index for the identified tumor cells. […]

Continue Reading